Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 27 entries
Sorted by: Best Match Show Resources per page
The role of microRNA in tumorigenesis: key players or innocent bystanders.

Journal of surgical oncology

Sini RA, Trink B, Nissan A.
PMID: 19072979
J Surg Oncol. 2009 Mar 01;99(3):135-6. doi: 10.1002/jso.21213.

No abstract available.

Cite
Sini RA, Trink B, Nissan A. The role of microRNA in tumorigenesis: key players or innocent bystanders. J Surg Oncol. 2009;99(3):135-6doi: 10.1002/jso.21213.
Sini, R. A., Trink, B., & Nissan, A. (2009). The role of microRNA in tumorigenesis: key players or innocent bystanders. Journal of surgical oncology, 99(3), 135-6. https://doi.org/10.1002/jso.21213
Sini, Raneen Abu, et al. "The role of microRNA in tumorigenesis: key players or innocent bystanders." Journal of surgical oncology vol. 99,3 (2009): 135-6. doi: https://doi.org/10.1002/jso.21213
Sini RA, Trink B, Nissan A. The role of microRNA in tumorigenesis: key players or innocent bystanders. J Surg Oncol. 2009 Mar 01;99(3):135-6. doi: 10.1002/jso.21213. PMID: 19072979.
Copy Download .nbib Format: NLM
Preface: MicroRNA: short but not small.

MicroRNA (Shariqah, United Arab Emirates)

Lin PY, Zhou X, Yang PC.
PMID: 25069506
Microrna. 2014;3(1):1. doi: 10.2174/221153660301140707105039.

No abstract available.

Cite
Lin PY, Zhou X, Yang PC. Preface: MicroRNA: short but not small. Microrna. 2014;3(1):1doi: 10.2174/221153660301140707105039.
Lin, P. Y., Zhou, X., & Yang, P. C. (2014). Preface: MicroRNA: short but not small. MicroRNA (Shariqah, United Arab Emirates), 3(1), 1. https://doi.org/10.2174/221153660301140707105039
Lin, Pei-Ying, et al. "Preface: MicroRNA: short but not small." MicroRNA (Shariqah, United Arab Emirates) vol. 3,1 (2014): 1. doi: https://doi.org/10.2174/221153660301140707105039
Lin PY, Zhou X, Yang PC. Preface: MicroRNA: short but not small. Microrna. 2014;3(1):1. doi: 10.2174/221153660301140707105039. PMID: 25069506.
Copy Download .nbib Format: NLM
Prognostic Value of miR-375 for Survival Outcomes in Various Cancers: A Systematic Review and Meta-Analysis.

Oncology research and treatment

Dan B, Luo J, Li K, Chen S.
PMID: 29402861
Oncol Res Treat. 2018;41(1):47-50. doi: 10.1159/000481708. Epub 2018 Jan 22.

BACKGROUND: miR-375 plays a role in tumor progression; however, its potential as a prognostic factor in cancer remains unclear. This meta-analysis assessed the value of miR-375 as a global prognostic biomarker in human cancer.METHODS: A systematic literature review was...

Cite
Dan B, Luo J, Li K, et al. Prognostic Value of miR-375 for Survival Outcomes in Various Cancers: A Systematic Review and Meta-Analysis. Oncol Res Treat. 2018;41(1):47-50doi: 10.1159/000481708.
Dan, B., Luo, J., Li, K., & Chen, S. (2018). Prognostic Value of miR-375 for Survival Outcomes in Various Cancers: A Systematic Review and Meta-Analysis. Oncology research and treatment, 41(1), 47-50. https://doi.org/10.1159/000481708
Dan, Bing, et al. "Prognostic Value of miR-375 for Survival Outcomes in Various Cancers: A Systematic Review and Meta-Analysis." Oncology research and treatment vol. 41,1 (2018): 47-50. doi: https://doi.org/10.1159/000481708
Dan B, Luo J, Li K, Chen S. Prognostic Value of miR-375 for Survival Outcomes in Various Cancers: A Systematic Review and Meta-Analysis. Oncol Res Treat. 2018;41(1):47-50. doi: 10.1159/000481708. Epub 2018 Jan 22. PMID: 29402861.
Copy Download .nbib Format: NLM
MicroRNAs and cancer: introduction.

Seminars in oncology

Garzon R, Croce CM.
PMID: 22082757
Semin Oncol. 2011 Dec;38(6):721-3. doi: 10.1053/j.seminoncol.2011.08.008.

No abstract available.

Cite
Garzon R, Croce CM. MicroRNAs and cancer: introduction. Semin Oncol. 2011;38(6):721-3doi: 10.1053/j.seminoncol.2011.08.008.
Garzon, R., & Croce, C. M. (2011). MicroRNAs and cancer: introduction. Seminars in oncology, 38(6), 721-3. https://doi.org/10.1053/j.seminoncol.2011.08.008
Garzon, Ramiro, and Croce, Carlo M. "MicroRNAs and cancer: introduction." Seminars in oncology vol. 38,6 (2011): 721-3. doi: https://doi.org/10.1053/j.seminoncol.2011.08.008
Garzon R, Croce CM. MicroRNAs and cancer: introduction. Semin Oncol. 2011 Dec;38(6):721-3. doi: 10.1053/j.seminoncol.2011.08.008. PMID: 22082757.
Copy Download .nbib Format: NLM
Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment.

Seminars in oncology

Sandhu S, Garzon R.
PMID: 22082764
Semin Oncol. 2011 Dec;38(6):781-7. doi: 10.1053/j.seminoncol.2011.08.007.

Early studies have established that microRNAs (miRNAs) are widely deregulated in cancer and play a critical role in cancer pathogenesis. Recent research efforts are directed now towards translating these basic discoveries into novel tests or treatments that could improve...

Cite
Sandhu S, Garzon R. Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment. Semin Oncol. 2011;38(6):781-7doi: 10.1053/j.seminoncol.2011.08.007.
Sandhu, S., & Garzon, R. (2011). Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment. Seminars in oncology, 38(6), 781-7. https://doi.org/10.1053/j.seminoncol.2011.08.007
Sandhu, Sukhinder, and Garzon, Ramiro. "Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment." Seminars in oncology vol. 38,6 (2011): 781-7. doi: https://doi.org/10.1053/j.seminoncol.2011.08.007
Sandhu S, Garzon R. Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment. Semin Oncol. 2011 Dec;38(6):781-7. doi: 10.1053/j.seminoncol.2011.08.007. PMID: 22082764.
Copy Download .nbib Format: NLM
Two decades of miRNA biology: lessons and challenges.

RNA (New York, N.Y.)

Lai EC.
PMID: 25780186
RNA. 2015 Apr;21(4):675-7. doi: 10.1261/rna.051193.115.

No abstract available.

Cite
Lai EC. Two decades of miRNA biology: lessons and challenges. RNA. 2015;21(4):675-7doi: 10.1261/rna.051193.115.
Lai, E. C. (2015). Two decades of miRNA biology: lessons and challenges. RNA (New York, N.Y.), 21(4), 675-7. https://doi.org/10.1261/rna.051193.115
Lai, Eric C. "Two decades of miRNA biology: lessons and challenges." RNA (New York, N.Y.) vol. 21,4 (2015): 675-7. doi: https://doi.org/10.1261/rna.051193.115
Lai EC. Two decades of miRNA biology: lessons and challenges. RNA. 2015 Apr;21(4):675-7. doi: 10.1261/rna.051193.115. PMID: 25780186; PMCID: PMC4371328.
Copy Download .nbib Format: NLM
RNAi, microRNAs, and human disease.

Cancer chemotherapy and pharmacology

Hammond SM.
PMID: 17093929
Cancer Chemother Pharmacol. 2006 Nov;58:s63-8. doi: 10.1007/s00280-006-0318-2.

MicroRNAs (miRNAs) are short, noncoding RNAs that posttranscriptionally regulate gene expression. Over 300 miRNA genes have been identified in the human genome. We have undertaken the study of miRNA function in mammals. Using a custom microarray platform, we investigated...

Cite
Hammond SM. RNAi, microRNAs, and human disease. Cancer Chemother Pharmacol. 2006;58:s63-8doi: 10.1007/s00280-006-0318-2.
Hammond, S. M. (2006). RNAi, microRNAs, and human disease. Cancer chemotherapy and pharmacology, 58s63-8. https://doi.org/10.1007/s00280-006-0318-2
Hammond, Scott M. "RNAi, microRNAs, and human disease." Cancer chemotherapy and pharmacology vol. 58 (2006): s63-8. doi: https://doi.org/10.1007/s00280-006-0318-2
Hammond SM. RNAi, microRNAs, and human disease. Cancer Chemother Pharmacol. 2006 Nov;58:s63-8. doi: 10.1007/s00280-006-0318-2. PMID: 17093929.
Copy Download .nbib Format: NLM
Issue @ a glance.

European heart journal

Lüscher TF.
PMID: 25452461
Eur Heart J. 2014 Dec 01;35(45):3143-4. doi: 10.1093/eurheartj/ehu452.

No abstract available.

Cite
Lüscher TF. Issue @ a glance. Eur Heart J. 2014;35(45):3143-4doi: 10.1093/eurheartj/ehu452.
Lüscher, T. F. (2014). Issue @ a glance. European heart journal, 35(45), 3143-4. https://doi.org/10.1093/eurheartj/ehu452
Lüscher, Thomas F. "Issue @ a glance." European heart journal vol. 35,45 (2014): 3143-4. doi: https://doi.org/10.1093/eurheartj/ehu452
Lüscher TF. Issue @ a glance. Eur Heart J. 2014 Dec 01;35(45):3143-4. doi: 10.1093/eurheartj/ehu452. PMID: 25452461.
Copy Download .nbib Format: NLM
MiRNAs as potential molecular targets in heart failure.

Future cardiology

Katz MG, Fargnoli AS, Williams RD, Kendle AP, Steuerwald NM, Bridges CR.
PMID: 25495820
Future Cardiol. 2014 Nov;10(6):789-800. doi: 10.2217/fca.14.64.

Pathogenesis of heart diseases is associated with an altered expression profile of hundreds of genes. miRNAs are a newly identified layer of gene regulation operating at the post-transcriptional level by pairing to complementary base sequences in target mRNAs. Genetic...

Cite
Katz MG, Fargnoli AS, Williams RD, et al. MiRNAs as potential molecular targets in heart failure. Future Cardiol. 2014;10(6):789-800doi: 10.2217/fca.14.64.
Katz, M. G., Fargnoli, A. S., Williams, R. D., Kendle, A. P., Steuerwald, N. M., & Bridges, C. R. (2014). MiRNAs as potential molecular targets in heart failure. Future cardiology, 10(6), 789-800. https://doi.org/10.2217/fca.14.64
Katz, Michael G, et al. "MiRNAs as potential molecular targets in heart failure." Future cardiology vol. 10,6 (2014): 789-800. doi: https://doi.org/10.2217/fca.14.64
Katz MG, Fargnoli AS, Williams RD, Kendle AP, Steuerwald NM, Bridges CR. MiRNAs as potential molecular targets in heart failure. Future Cardiol. 2014 Nov;10(6):789-800. doi: 10.2217/fca.14.64. PMID: 25495820.
Copy Download .nbib Format: NLM
The relationship of MicroRNA-21 and plaque stability in acute coronary syndrome.

Medicine

He W, Zhu L, Huang Y, Zhang Y, Shen W, Fang L, Li J, Wang Z, Xie Q.
PMID: 31764830
Medicine (Baltimore). 2019 Nov;98(47):e18049. doi: 10.1097/MD.0000000000018049.

Acute coronary syndrome (ACS) leads to clinical symptoms such as chest pain, dyspnea, and arrhythmia. The occurrence of ACS is mainly related to the vulnerable plaques in the coronary arteries. MicroRNA-21 (miR-21) is widely expressed in cardiovascular disease and...

Cite
He W, Zhu L, Huang Y, et al. The relationship of MicroRNA-21 and plaque stability in acute coronary syndrome. Medicine (Baltimore). 2019;98(47):e18049doi: 10.1097/MD.0000000000018049.
He, W., Zhu, L., Huang, Y., Zhang, Y., Shen, W., Fang, L., Li, J., Wang, Z., & Xie, Q. (2019). The relationship of MicroRNA-21 and plaque stability in acute coronary syndrome. Medicine, 98(47), e18049. https://doi.org/10.1097/MD.0000000000018049
He, Wangwei, et al. "The relationship of MicroRNA-21 and plaque stability in acute coronary syndrome." Medicine vol. 98,47 (2019): e18049. doi: https://doi.org/10.1097/MD.0000000000018049
He W, Zhu L, Huang Y, Zhang Y, Shen W, Fang L, Li J, Wang Z, Xie Q. The relationship of MicroRNA-21 and plaque stability in acute coronary syndrome. Medicine (Baltimore). 2019 Nov;98(47):e18049. doi: 10.1097/MD.0000000000018049. PMID: 31764830; PMCID: PMC6882643.
Copy Download .nbib Format: NLM
An introduction to small non-coding RNAs: miRNA and snoRNA.

Cardiovascular drugs and therapy

Holley CL, Topkara VK.
PMID: 21573765
Cardiovasc Drugs Ther. 2011 Apr;25(2):151-9. doi: 10.1007/s10557-011-6290-z.

Research into small non-coding RNAs (ncRNA) has fundamentally transformed our understanding of gene regulatory networks, especially at the post-transcriptional level. Although much is now known about the basic biology of small ncRNAs, our ability to recognize the impact of...

Cite
Holley CL, Topkara VK. An introduction to small non-coding RNAs: miRNA and snoRNA. Cardiovasc Drugs Ther. 2011;25(2):151-9doi: 10.1007/s10557-011-6290-z.
Holley, C. L., & Topkara, V. K. (2011). An introduction to small non-coding RNAs: miRNA and snoRNA. Cardiovascular drugs and therapy, 25(2), 151-9. https://doi.org/10.1007/s10557-011-6290-z
Holley, Christopher L, and Topkara, Veli K. "An introduction to small non-coding RNAs: miRNA and snoRNA." Cardiovascular drugs and therapy vol. 25,2 (2011): 151-9. doi: https://doi.org/10.1007/s10557-011-6290-z
Holley CL, Topkara VK. An introduction to small non-coding RNAs: miRNA and snoRNA. Cardiovasc Drugs Ther. 2011 Apr;25(2):151-9. doi: 10.1007/s10557-011-6290-z. PMID: 21573765.
Copy Download .nbib Format: NLM
The role of microRNAs in the initiation and progression of stable atheromatous plaque.

Current pharmaceutical design

Papageorgiou N, Tousoulis D, Androulakis E, Kontogeorgou A, Charakida M, Giolis A, Siama K, Trikas A, Briasoulis A, Pitsavos C, Stefanadis C.
PMID: 23016721
Curr Pharm Des. 2013;19(9):1651-7.

Atherosclerosis is a chronic process related to several underlying mechanisms leading to the formation and evolution of atherosclerotic plaque. Of great interest are during the last years short, non-coding RNAs, called microRNAs and responsible for several aspects of homeostasis...

Cite
Papageorgiou N, Tousoulis D, Androulakis E, et al. The role of microRNAs in the initiation and progression of stable atheromatous plaque. Curr Pharm Des. 2013;19(9):1651-7
Papageorgiou, N., Tousoulis, D., Androulakis, E., Kontogeorgou, A., Charakida, M., Giolis, A., Siama, K., Trikas, A., Briasoulis, A., Pitsavos, C., & Stefanadis, C. (2013). The role of microRNAs in the initiation and progression of stable atheromatous plaque. Current pharmaceutical design, 19(9), 1651-7.
Papageorgiou, Nikolaos, et al. "The role of microRNAs in the initiation and progression of stable atheromatous plaque." Current pharmaceutical design vol. 19,9 (2013): 1651-7.
Papageorgiou N, Tousoulis D, Androulakis E, Kontogeorgou A, Charakida M, Giolis A, Siama K, Trikas A, Briasoulis A, Pitsavos C, Stefanadis C. The role of microRNAs in the initiation and progression of stable atheromatous plaque. Curr Pharm Des. 2013;19(9):1651-7. PMID: 23016721.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 27 entries